-

CADL Investors Have Opportunity to Join Candel Therapeutics, Inc. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)--Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Candel Therapeutics, Inc. (“Candel” or “the Company”) (NASDAQ: CADL) for violations of the securities laws.

INVESTIGATION DETAILS: The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Candel announced on November 12, 2026, that it expects to submit its Biologics License Application (BLA) for aglatimagene in mid-2027. The Company had previously stated it was on track to submit the BLA in Q4 2026. Based on this news, shares of Candel fell sharply on the same day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall or David Schwartz of Schall, Brown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at david@schallfirm.com.

WHY SBS? Schall, Brown & Schwartz LLP represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. Bringing together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is dedicated to aggressively advocating for every investor.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Contacts

Schall, Brown & Schwartz LLP
Brian Schall, Esq.
Andrew Brown, Esq.
David Schwartz, Esq.
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com

Schall, Brown & Schwartz LLP

NASDAQ:CADL

Release Summary
CADL Investors Have Opportunity to Join Candel Therapeutics, Inc. Fraud Investigation with SBS Law
Release Versions
$Cashtags

Contacts

Schall, Brown & Schwartz LLP
Brian Schall, Esq.
Andrew Brown, Esq.
David Schwartz, Esq.
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com

More News From Schall, Brown & Schwartz LLP

MLI Investors Have Opportunity to Join Mueller Industries, Inc. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)--MLI Investors Have Opportunity to Join Mueller Industries, Inc. Fraud Investigation with SBS Law...

ARTV Investors Have Opportunity to Join Artiva Biotherapeutics, Inc. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)--ARTV Investors Have Opportunity to Join Artiva Biotherapeutics, Inc. Fraud Investigation with SBS Law...

CACC Investors Have Opportunity to Join Credit Acceptance Corporation Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)--CACC Investors Have Opportunity to Join Credit Acceptance Corporation Fraud Investigation with SBS Law...
Back to Newsroom